3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
10
Observational
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Melanoma
11
Lung Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasms
5
Head and Neck Neoplasms
3
Carcinoma, Renal Cell
3
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Urinary Bladder Neoplasms
1
Uncommon Pathological Types of Lung Cancer
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
NSCLC
1
Motor Activity
1
Lung Squamous Cell Carcinoma Stage IV
1
Lung Diseases, Interstitial
1
Liver Diseases
1
Kidney Neoplasms
1
Interventions
Thyroidectomy
5
Iodine-131
5
Surgical Procedures, Operative
3
selpercatinib
2
lenvatinib
2
anlotinib
2
Ultrasonography
2
Transurethral Resection of Prostate
2
Sorafenib
2
Molecular Diagnostic Techniques
2
Interviews as Topic
2
Focus Groups
2
Biopsy, Fine-Needle
2
trastuzumab deruxtecan
1
trametinib
1
pralsetinib
1
pembrolizumab
1
gallium Ga 68 dotatate
1
dabrafenib
1
Triiodothyronine
1
Thyroxine
1
Thyrotropin Alfa
1
Surveys and Questionnaires
1
Routinely Collected Health Data
1
Radiotherapy, Adjuvant
1
Quality of Life
1
Patient Reported Outcome Measures
1
Observation
1
Nivolumab
1
Minimally Invasive Surgical Procedures
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Thyroid Neoplasms
×
pembrolizumab
×
Clear all
NCT07419932
2026-02-19
NeoLATC
Fujian Medical University
Recruiting
120 enrolled